Keurig Dr Pepper (NASDAQ:KDP) PT Raised to $36.00

Keurig Dr Pepper (NASDAQ:KDP) had its target price lifted by stock analysts at Barclays from $32.00 to $36.00 in a report issued on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 19.13% from the stock’s current price.

KDP has been the subject of a number of other research reports. Jefferies Financial Group lowered their target price on shares of Keurig Dr Pepper from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, March 27th. HSBC initiated coverage on shares of Keurig Dr Pepper in a research note on Friday, December 22nd. They issued a “hold” rating and a $37.00 price target for the company. Royal Bank of Canada decreased their price target on shares of Keurig Dr Pepper from $42.00 to $41.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. Morgan Stanley decreased their price target on shares of Keurig Dr Pepper from $37.00 to $34.00 and set an “equal weight” rating for the company in a research note on Monday, February 26th. Finally, Wedbush decreased their price target on shares of Keurig Dr Pepper from $37.00 to $35.00 and set an “outperform” rating for the company in a research note on Monday, February 26th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $36.45.

Keurig Dr Pepper Price Performance

Shares of NASDAQ KDP opened at $30.22 on Friday. Keurig Dr Pepper has a twelve month low of $27.66 and a twelve month high of $35.99. The firm has a fifty day simple moving average of $30.28 and a 200 day simple moving average of $31.02. The company has a market capitalization of $41.93 billion, a PE ratio of 19.50, a P/E/G ratio of 2.34 and a beta of 0.66. The company has a quick ratio of 0.25, a current ratio of 0.38 and a debt-to-equity ratio of 0.39.

Keurig Dr Pepper (NASDAQ:KDP) last announced its earnings results on Thursday, February 22nd. The company reported $0.55 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.01. Keurig Dr Pepper had a net margin of 14.72% and a return on equity of 9.93%. The business had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter last year, the firm earned $0.50 earnings per share. Keurig Dr Pepper’s quarterly revenue was up 1.7% on a year-over-year basis. On average, sell-side analysts forecast that Keurig Dr Pepper will post 1.91 EPS for the current year.

Insider Activity

In other Keurig Dr Pepper news, CEO Robert James Gamgort acquired 171,821 shares of Keurig Dr Pepper stock in a transaction dated Tuesday, March 5th. The stock was purchased at an average cost of $29.10 per share, for a total transaction of $4,999,991.10. Following the completion of the acquisition, the chief executive officer now directly owns 3,179,917 shares of the company’s stock, valued at $92,535,584.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO Robert James Gamgort purchased 171,821 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were acquired at an average cost of $29.10 per share, for a total transaction of $4,999,991.10. Following the completion of the acquisition, the chief executive officer now owns 3,179,917 shares in the company, valued at $92,535,584.70. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert S. Singer sold 12,132 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $29.25, for a total transaction of $354,861.00. Following the transaction, the director now owns 37,643 shares in the company, valued at $1,101,057.75. The disclosure for this sale can be found here. Insiders sold 100,012,132 shares of company stock worth $2,890,354,861 over the last three months. 0.81% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in KDP. Moneta Group Investment Advisors LLC boosted its holdings in Keurig Dr Pepper by 99,740.8% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 324,915,003 shares of the company’s stock worth $11,586,469,000 after purchasing an additional 324,589,570 shares during the last quarter. Capital World Investors boosted its stake in Keurig Dr Pepper by 14.6% in the fourth quarter. Capital World Investors now owns 108,032,566 shares of the company’s stock valued at $3,599,652,000 after acquiring an additional 13,738,345 shares during the last quarter. Norges Bank purchased a new position in Keurig Dr Pepper in the fourth quarter valued at about $317,979,000. FMR LLC boosted its stake in Keurig Dr Pepper by 12.9% in the third quarter. FMR LLC now owns 60,682,003 shares of the company’s stock valued at $1,915,731,000 after acquiring an additional 6,926,582 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in Keurig Dr Pepper by 7.2% in the third quarter. Vanguard Group Inc. now owns 82,196,547 shares of the company’s stock valued at $2,594,945,000 after acquiring an additional 5,490,242 shares during the last quarter. 85.23% of the stock is currently owned by hedge funds and other institutional investors.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.